A new target for treating intervertebral disk degeneration: gut microbes

Area of Science:

• Microbiology
• Orthopedics
• Gastroenterology

Background:

• Intervertebral disk degeneration (IDD) is a major cause of low back pain (LBP), often linked to aging but influenced by multiple factors.
• Current treatments for IDD are limited, with conservative methods offering minimal relief and surgery posing risks of invasiveness and recurrence.
• The gut microbiota, a complex microbial community, is increasingly recognized for its role in systemic health and disease.

Purpose of the Study:

• To explore the connection between gut microbiota and intervertebral disk degeneration (IDD).
• To elucidate the mechanisms through which gut microbes and their metabolites affect IDD.
• To identify potential therapeutic strategies for IDD by targeting the gut microbiota.

Main Methods:

• Review of existing literature on gut microbe impact on distal organs.
• Analysis of proposed mechanisms linking gut microbiota, metabolites, and IDD pathogenesis.
• Summary of interventions targeting gut microbiota for IDD management.

Main Results:

• Gut microbes influence distant organs, including potentially the intervertebral discs.
• Three key mechanisms illustrate how gut microbiota and metabolites impact IDD.
• Interfering with gut microbiota presents a novel approach for IDD treatment.

Conclusions:

• Gut microbiota plays a significant role in the development and progression of IDD.
• Understanding these gut-microbe-disc interactions is crucial for developing effective IDD therapies.
• Targeting the gut microbiota offers promising avenues for managing low back pain associated with IDD.